share_log

Engagesmart Analyst Ratings

Benzinga ·  Jul 13, 2023 05:51
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
07/13/2023 7.25% Goldman Sachs → $21 Downgrades Buy → Neutral
06/27/2023 27.68% Raymond James $24 → $25 Maintains Strong Buy
06/16/2023 104.29% Needham → $40 Reiterates Buy → Buy
05/08/2023 2.15% Keybanc $26 → $20 Maintains Overweight
05/05/2023 53.22% Truist Securities $35 → $30 Maintains Buy
05/05/2023 12.36% Craig-Hallum → $22 Initiates Coverage On → Buy
05/05/2023 2.15% Citigroup $26 → $20 Maintains Buy
05/05/2023 22.57% Raymond James $27 → $24 Maintains Strong Buy
04/13/2023 7.25% Goldman Sachs $24 → $21 Maintains Buy
03/13/2023 104.29% Needham → $40 Reiterates → Buy
02/10/2023 22.57% Goldman Sachs $21 → $24 Maintains Buy
02/10/2023 104.29% Needham → $40 Reiterates → Buy
02/10/2023 32.79% Keybanc $25 → $26 Maintains Overweight
01/23/2023 17.47% Deutsche Bank $26 → $23 Maintains Hold
01/09/2023 7.25% Goldman Sachs $24 → $21 Maintains Buy
11/04/2022 22.57% Goldman Sachs $27 → $24 Maintains Buy
11/04/2022 37.9% Raymond James $31 → $27 Maintains Strong Buy
08/05/2022 27.68% Keybanc $20 → $25 Maintains Overweight
07/07/2022 2.15% Keybanc $25 → $20 Maintains Overweight
05/06/2022 58.32% Raymond James $35 → $31 Maintains Strong Buy
04/08/2022 48.11% Goldman Sachs $34 → $29 Maintains Buy
03/16/2022 27.68% Keybanc $30 → $25 Maintains Overweight
02/16/2022 78.75% Raymond James $34 → $35 Maintains Strong Buy
02/16/2022 53.22% Keybanc $25 → $30 Maintains Overweight
01/26/2022 32.79% Citigroup $31 → $26 Maintains Buy
01/25/2022 27.68% Keybanc $40 → $25 Maintains Overweight
01/11/2022 73.65% Raymond James $40 → $34 Maintains Strong Buy
12/14/2021 53.22% JP Morgan $35 → $30 Maintains Neutral
12/13/2021 73.65% Goldman Sachs $44 → $34 Maintains Buy
12/09/2021 58.32% Citigroup → $31 Upgrades Neutral → Buy
11/30/2021 104.29% Raymond James → $40 Upgrades Outperform → Strong Buy
11/15/2021 78.75% B of A Securities → $35 Upgrades Neutral → Buy
10/18/2021 129.83% Truist Securities → $45 Initiates Coverage On → Buy
10/18/2021 William Blair Initiates Coverage On → Outperform
10/18/2021 88.97% Deutsche Bank → $37 Initiates Coverage On → Hold
10/18/2021 78.75% B of A Securities → $35 Initiates Coverage On → Neutral
10/18/2021 124.72% Goldman Sachs → $44 Initiates Coverage On → Buy
10/18/2021 104.29% Raymond James → $40 Initiates Coverage On → Outperform
10/18/2021 104.29% Needham → $40 Initiates Coverage On → Buy
10/18/2021 78.75% JP Morgan → $35 Initiates Coverage On → Neutral
10/18/2021 104.29% Keybanc → $40 Initiates Coverage On → Overweight

What is the target price for Engagesmart (ESMT)?

The latest price target for Engagesmart (NYSE: ESMT) was reported by Goldman Sachs on July 13, 2023. The analyst firm set a price target for $21.00 expecting ESMT to rise to within 12 months (a possible 7.25% upside). 18 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Engagesmart (ESMT)?

The latest analyst rating for Engagesmart (NYSE: ESMT) was provided by Goldman Sachs, and Engagesmart downgraded their neutral rating.

When is the next analyst rating going to be posted or updated for Engagesmart (ESMT)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Engagesmart, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Engagesmart was filed on July 13, 2023 so you should expect the next rating to be made available sometime around July 13, 2024.

Is the Analyst Rating Engagesmart (ESMT) correct?

While ratings are subjective and will change, the latest Engagesmart (ESMT) rating was a downgraded with a price target of $0.00 to $21.00. The current price Engagesmart (ESMT) is trading at is $19.58, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment